156 results about "Diethylene glycol monoethyl ether" patented technology

The invention belongs to the technical field of medicines, and particularly relates to an azilsartan tablet. The azilsartan tablet contains azilsartan, hydroxy propyl cellulose and fumed silica, and is prepared by the following steps: dissolving the azilsartan and the hydroxy propyl cellulose in diethylene glycol monoethyl ether, adding the fumed silica to adsorb, uniformly mixing with pharmaceutically acceptable auxiliary materials and pressing by a direct tableting process. Compared with the prior art, the azilsartan tablet is high in drug dissolution speed and simple in process.

The present invention relates to a liquid pest control system that includes a synthetic pyrethroid as a pest control active ingredient and an agent selected from the group consisting of purified diethylene glycol monoethyl ether, tocopherol nicotinate and tocopherol succinate, and combinations thereof, to reduce or eliminate paraesthesia of the synthetic pyrethroid. The system releases the synthetic pyrethroid efficiently and uniformly. The pest control system is less irritating to the animal's skin as compared to prior art systems, particularly to the small breeds of dogs. The system is useful for making liquid spot-on treatments, sprays and the like.

The invention belongs to the technical field of drugs and in particular relates to a rivaroxaban tablet. The rivaroxaban tablet contains rivaroxaban, hydroxypropyl cellulose and fumed silica and is prepared by dissolving rivaroxaban and hydroxypropyl cellulose in diethylene glycol monoethyl ether, adding fumed silica for adsorption, then mixing the materials with pharmaceutically acceptable auxiliary materials uniformly and pressing the mixture by adopting a direct tabletting process. Compared with the prior art, the rivaroxaban tablet is high in drug dissolution speed and simple in process and dispenses with addition of surfactants and micronization treatment.

Solubility, absorption, and permeability of drugs upon oral administration are improved when the drugs are mixed and/or complexed with water-miscible organic solvents. Illustratively, the absorption of a heparin-deoxycholic acid conjugate upon oral administration is increased by mixing and/or complexing this conjugate with dimethyl sulfoxide. Other illustrative water-miscible organic solvents include N-methylpyrrolidone, polyoxyl 35 castor oil, diethylene glycol monoethyl ether, and benzoic acid.

The invention belongs to the technical field of water treatment, and particularly relates to sustained-release nano-calcium peroxide materials, preparation thereof, and a method for removing chlorohydrocarbon and benzene series from underground water by strengthening and activating the sustained-release nano-calcium peroxide materials through ferrous sulfide. By taking calcium chloride, hydrogen peroxide with the mass fraction being 30% and ammonium hydroxide with the mass fraction being 30% as raw materials and by adding different dispersing agents, an irreversible coagulation phenomenon is avoided in the synthesis process, then by adding different macromolecular polymers such as polyethylene glycol 400 (PEG400), polyvinyl alcohol (PVA) and diethylene glycol monoethyl ether (DEGMME), a film is formed on the surface of nCaO2, and through processes such as washing with water and ethyl alcohol and vacuum drying, the sustained-release nano-calcium peroxide advanced oxidation materials embedded with the various macromolecular polymers are obtained. By applying the oxidation materials, the purposes of efficient and lasting treatment of pollutants and lowering of the repair cost of the underground water in contaminated sites are achieved.

The invention belongs to the technical field of medicines, and in particular relates to an anhydroicaritin tablet. The anhydroicaritin tablet contains anhydroicaritin, hydroxy propyl cellulose, fumed silica, diethylene glycol monoethyl ether and other pharmaceutically acceptable auxiliary materials. A preparation method comprises the following steps: dissolving anhydroicaritin and hydroxy propyl cellulose in diethylene glycol monoethyl ether, adding with fumed silica for adsorption, then uniformly mixing with the pharmaceutically acceptable auxiliary materials, and carrying out pressing by adopting a direct tableting technology. The medicine dissolution speed is high, the process is simple, a surfactant does not need to be added, and the micronization treatment is not needed. The acceleration test result shows that the prepared anhydroicaritin tablet is good in stability.

This invention is directed to a pharmaceutical composition for drinking water administration comprising isoxazoline compounds of formula (I) and a polysorbate surfactant and diethylene glycol monoethyl ether (transcutol); and the use of the composition to treat or prevent parasite infestations of animals.

The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to an apixaban tablet. The apixaban tablet contains apixaban, hydroxy propyl cellulose and fumed silica. A preparation method of the apixaban tablet comprises the following steps: dissolving apixaban and hydroxy propyl cellulose in diethylene glycol monoethyl ether, adding with fumed silica for adsorption, then uniformly mixing with pharmaceutically acceptable auxiliary materials, and carrying out pressing by adopting a direct tableting technology. Compared with the prior art, the apixaban tablet has the advantages that the medicine dissolution speed is high, the process is simple, a surfactant does not need to be added, and the micronization treatment is not needed. The acceleration test result shows that the prepared apixaban tablet is good in stability.

The invention belongs to the technical field of drugs and in particular relates to an ezetimibe tablet. The ezetimibe tablet comprises ezetimibe, hydroxypropyl cellulose, diethylene glycol monoethyl ether, fumed silica, filling agents, disintegrating agents and lubricating agents. The tablet is prepared by dissolving ezetimibe and hydroxypropyl cellulose in diethylene glycol monoethyl ether, adding fumed silica for adsorption, then mixing the materials with pharmaceutically acceptable auxiliary materials uniformly and pressing the mixture by adopting a direct tabletting process. Compared with the prior art, the ezetimibe tablet is high in drug dissolution speed and simple in process and dispenses with addition of surfactants and micronization treatment.

The invention discloses a dustproof and bactericidal type aqueous coating material for glass doors. The dustproof and bactericidal type aqueous coating material is characterized by being prepared from the following raw materials in parts by weight: 34-38 parts of aqueous polyurethane resin, 28-34 parts of acrylic epoxy resin, 8-12 parts of modified styrene-acrylic emulsion, 0.4-0.8 part of polyvinyl alcohol, 1-3 parts of diethylene glycol monoethyl ether, 0.3-0.6 part of alcohol-amine dipyrophosphate acyloxy glycolate titanate, 0.2-0.5 part of polyether modified polyorganosiloxane, 0.2-0.4 part of cellaburate, 0.3-0.6 part of dioctyl sodium sulfosuccinate, 0.4-0.7 part of acetoacetoxy ethyl methacrylate, 0.6-1.2 parts of climbazole, 3-5 parts of ethylene glycol, 0.5-1.0 part of graphene, 1-2 parts of pigment and 10-15 parts of deionized water. According to the aqueous coating material disclosed by the invention, on the basis of high adhesion, water resistance and alcohol acid resistance, the modified styrene-acrylic emulsion is added, so that the bactericidal, dustproof and anti-electrostatic effects of the coating material are improved; added climbazole has spectrum sterilization property, so that the quality of the coating material is further improved; and the coating material disclosed by the invention is simple in operation and low in production cost, does not contain benzene solvents and heavy metals, is harmless to human bodies and environment, is environment-friendly and safe and is suitable for being popularized.

The invention belongs to the technical field of medicines, and specifically relates to aprepitant capsules. The aprepitant capsules contain aprepitant, hydroxy propyl cellulose, diethylene glycol monoethyl ether, fumed silica and other pharmaceutically acceptable filler, disintegrant and lubricant. A preparation method of the aprepitant capsules comprises the following steps: dissolving aprepitant in diethylene glycol monoethyl ether, adding hydroxy propyl cellulose, stirring to dissolve, adding fumed silica to adsorb, then uniformly mixing with the other pharmaceutically acceptable filler, disintegrant and lubricant, and directly filling capsules. Compared with the prior art, the aprepitant capsules disclosed by the invention are fast in medicine dissolution speed, simple in process, and free from a surfactant and a micronization treatment. An acceleration test result indicates that the prepared aprepitant capsules are high in dissolution rate.